Inhibrx Biosciences CEO Mark Lappe acquires $984,588 of common shares
Open-market purchases were disclosed via the Lappe Family Trust; trust holdings rose to 740,548 shares.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.